A computational method for the estimation of atrophic changes in Alzheimer's disease and mild cognitive impairment

Computerized Medical Imaging and Graphics

Volumn 32, Issue 4, 2008, Pages 294-303

  Fritzsche, Klaus H ^a   von Wangenheim, Aldo ^b   Abdala, Daniel Duarte ^c   Meinzer, Hans Peter ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

^c Fachbereich Mathematik und Informatik   (Germany)

Author keywords

Alzheimer's disease; Atrophy; Computer aided diagnosis; Dementia; Magnetic resonance imaging; Mild cognitive impairment; Tissue volumetry

Indexed keywords

COMPUTER AIDED DIAGNOSIS; MAGNETIC RESONANCE IMAGING; PATIENT MONITORING;

ALZHEIMER'S DISEASE; DEMENTIA; MILD COGNITIVE IMPAIRMENT; TISSUE VOLUMETRY;

MEDICAL PROBLEMS;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN ATROPHY; CALCULATION; CLINICAL ARTICLE; CLINICAL PRACTICE; COGNITIVE DEFECT; CONTROLLED STUDY; DISEASE COURSE; FEMALE; HUMAN; IMAGE ANALYSIS; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PHYSICIAN; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; ATROPHY; CASE-CONTROL STUDIES; COGNITION DISORDERS; DIAGNOSIS, COMPUTER-ASSISTED; DISEASE PROGRESSION; FEMALE; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; SENSITIVITY AND SPECIFICITY; SOFTWARE; STATISTICS, NONPARAMETRIC;

EID: 41849127021     PISSN: 08956111     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.compmedimag.2007.12.006     Document Type: Article

References (34)

1. World Health Organisation. Priority Medicines for Europe and the World. November 2005. Available at http://mednet3.who.int/prioritymeds/.
2. National Institutes of Health (NIH). Progress Report on Alzheimer's Disease 2004-2005. November 2005. NIH Publication Number: 05-5724.
3. Bennett D.A., Schneider J.A., Bienias J.L., Evans D.A., and Wilson R.S. Mild cognitive impairment is related to Alzheimer's disease pathology and cerebral infarctions. Neurology 64 (2005) 834-841
4. Petersen R.C., Stevens J.C., Ganguli M., Tangalos E.G., Cummings J.L., and DeKosky S.T. Practice parameter: early detection of dementia: mild cognitive impairment (an evidence-based review). Neurology 56 (2001) 1133-1142 Report of the Quality Standards Subcommittee of the American Academy of Neurology
5. Folstein M.F., Folstein S.E., and McHugh P.R. Mini-Mental State: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12 (1975) 189-198
6. Knopman D.S., DeKosky S.T., Cummings J.L., Chui H., Corey-Bloom J., Relkin N., Small G.W., Miller B., and Stevens J.C. Practice parameter: diagnosis of dementia (an evidence-based review). Neurology 56 (2001) 1143-1153 Report of the Quality Standards Subcommittee of the American Academy of Neurology
7. Albert M, DeCarli C, DeKosky S, de Leon M, Foster NL, Fox N, et al.. The Use of MRI and PET for Clinical Diagnosis of Dementia and Investigation of Cognitive Impairment: A Consensus Report. Prepared by the Neuroimaging Work Group of the Alzheimer's Association, April 2004. Available at: http://www.alz.org/national/documents/Imaging_consensus_report.pdf.
8. George A., de Leon M., Golomb J., Kluger A., and Convit A. Imaging the brain in dementia: expensive and futile?. Am J Neuroradiol 18 (1997) 1847-1850
9. Frisoni G.B., Laakso M.P., Beltramello A., Geroldi C., Bianchetti A., Soininen H., and Trabucchi M. Hippocampal and entorhinal cortex atrophy in frontotemporal dementia and Alzheimer's disease. Neurology 52 (1999) 91-100
10. de Leon M.J., Golomb J., et al. The radiologic prediction of Alzheimer's disease: the atrophic hippocampal formation. Am J Neuroradiol 14 (1993) 897
11. Erkinjuntti T., Lee D.H., Gao F., Steenhuis R., Eliasziw M., Fry R., Merskey H., and Hachinski V.C. Temporal lobe atrophy on magnetic resonance imaging in the diagnosis of early Alzheimer's disease. Arch Neurol 50 (1993) 305-310
12. Bottino C.M., Castro C.C., Gomes R.L., Buchpiguel C.A., Marchetti R.L., and Neto M.R. Volumetric MRI measurements can differentiate Alzheimer's disease, mild cognitive impairment, and normal aging. Int Psychogeriatr 14 (2002) 59-72
13. Gosche K.M., Mortimer J.A., Smith C.D., Markesbery W.R., and Snowdon D.A. Hippocampal volume as an index of Alzheimer neuropathology: findings from the Nun Study. Neurology 58 (2002) 1476-1482
14. van de Pol L.A., Hensel A., van der Flier W.M., Visser P.J., Pijnenburg Y.A.L., Barkhof F., Gertz H.J., and Scheltens P. Hippocampal atrophy on MRI in Frontotemporal lobar degeneration and Alzheimer's disease. J Neurol Neurosurg Psychiatry 77 (2006) 439-442
15. Holodny AI, Waxman R, George AE, Rusinek H, Kalnin AJ, de Leon M. MR differential diagnosis of normal-pressure hydrocephalus and Alzheimer disease: significance of perihippocampal fissures. Am J Neuroradiol; 19.
16. In: Thacker N.A., Varma A.R., Bathgate D., Snowden J.S., Neary D., and Jackson A. (Eds). Quantification of the Severity and Distribution of Cerebral Atrophy Provides Diagnostic Information in Dementing Diseases. Proc (2000), MIUA
17. Le May M., Starord J., Sandor T., Albert M., Haykal B., and Zamani A. Statistical assessment of perceptual CT scan ratings in patients with Alzheimer type dementia. J Comput Assist Tomogr 10 (1986) 802-809
18. Laakso M., Soininen H., Partanen K., Hallikainen M., Lehtovirta M., Hänninen T., et al. The interuncal distance in Alzheimer's disease and age-associated memory impairment. Am J Neuroradiol 16 (1995) 727-734
19. Seab J.P., Jagust W.J., Wong S.T.S., Roos M.S., Reed B.R., and Budinger T.F. Quantitative NMR measurements of hippocampal atrophy in Alzheimer's disease. Magn Reson Med 8 (1988) 200-208
20. Kesslak J.P., Nalcioglu O., and Cotman C.W. Quantification of magnetic resonance scans for hippocampal and parahippocampal atrophy in Alzheimer's disease. Neurology 41 (1991) 51-54
21. Jack C.R., Petersen R.C., O'Brien P.C., and Tangalos E.G. MR-based hippocampal volumetry in the diagnosis of Alzheimer's disease. Neurology 42 (1992) 183-188
22. Killiany R.J., Moss M.B., Albert M.S., Sandor T., Tieman J., and Jolesz F. Temporal lobe regions on magnetic resonance imaging identify patients with early Alzheimer's disease. Arch Neurol 50 (1993) 949-954
23. Frisoni G.B., Testa C., Zorzan A., Sabattoli F., Beltramello A., Soininen H., and Laakso M.P. Detection of grey matter loss in mild Alzheimer's disease with voxel based morphometry. J Neurol Neurosurg Psychiatry 73 (2002) 657-664
24. Thompson P.M., Hayashi K.M., de Zubicaray G., Janke A.L., Rose S.E., Semple J., et al. Dynamics of gray matter loss in Alzheimer's disease. J Neurosci 23 (2003) 994-1005
25. Rusinek H., Endo Y., De Santi S., Frid D., Tsui W.H., Segal S., et al. Atrophy rate in medial temporal lobe during progression of Alzheimer's disease. Neurology 63 (2004) 2354-2359
26. Bachman D.L., Wolf P.A., Linn R.T., Knoefel J.E., Cobb J.L., Belanger A.J., et al. Incidence of dementia and probable Alzheimer's disease in a general population. The Framingham Study. Neurology 43 (1993) 515-519
27. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 3rd ed. revised (1987), American Psychiatric Association, Washington, D.C
28. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. (1994), American Psychiatric Association, Washington, D.C
29. http://www.fil.ion.ucl.ac.uk/spm/, 2005. UCL Institute of Neurology. Statistical Parametric Mapping.
30. Ashburner J., and Friston K.J. Nonlinear spatial normalization using basis functions. Hum Brain Mapp 7 4 (1999) 254-266
31. Mazziotta J.C., Toga A., Evans A., Fox P., Lancaster J., Zilles K., et al. A probabilistic atlas and reference system for the human brain: International Consortium for Brain Mapping (ICBM). Philos Trans Royal Soc Lond Series B (Biol Sci) 356 1412 (2001) 1293-1322 Enclosed in Appendix II
32. Ashburner J., and Friston K.J. MRI sensitivity correction and tissue classification. NeuroImage 7 4 (1998) S107
33. http://www-ra.informatik.uni-tuebingen.de/SNNS/, 2000. Developed at University of Stuttgart, maintained at University of Tuebingen. Stuttgart Neural Network Simulator.
34. Jack C.R., Slomkowski M., Gracon S., Hoover T.M., Felmlee J.P., Stewart K., et al. MRI as a biomarker of disease progression in a therapeutic trial of milameline for AD. Neurology 60 (2003) 253-260